South-East Asia (WHO region) vs Turkmenistan: New cases tested for RR-/MDR-TB
South-East Asia (WHO region)
91.0%
in 2024
Turkmenistan
100.0%
in 2022
South-East Asia (WHO region) rank
1st
Turkmenistan rank
1st
New cases tested for RR-/MDR-TB over time
- South-East Asia (WHO region)
- Turkmenistan
How they compare
Turkmenistan currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.
That makes Turkmenistan's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 1 time across 8 shared years of data; in 2006 it was South-East Asia (WHO region) ahead.
South-East Asia (WHO region) ranks 1st and Turkmenistan ranks 1st of 11 groups.
Turkmenistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South-East Asia (WHO region) | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 6.0% | 5.9% | Turkmenistan |
| 2010s | 20.2% | 45.0% | 24.8% | Turkmenistan |
| 2020s | 73.0% | 100.0% | 27.0% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, South-East Asia (WHO region) or Turkmenistan?
- Turkmenistan, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2022.
- What is the difference in new cases tested for rr-/mdr-tb between South-East Asia (WHO region) and Turkmenistan?
- 9.0%, with Turkmenistan ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Turkmenistan?
- 8 years are reported by both, from 2006 to 2022.
- How do South-East Asia (WHO region) and Turkmenistan rank globally for new cases tested for rr-/mdr-tb?
- South-East Asia (WHO region) ranks 1st and Turkmenistan ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.